Maryland Statutes
Subtitle 6A - Therapy Management Contracts
Section 12-6A-01 - Definitions

(a)    In this subtitle the following words have the meanings indicated.
    (b)    “Authorized prescriber” means a licensed physician, licensed podiatrist, or certified advanced practice nurse with prescriptive authority under § 8–508 of this article.
    (c)    “Group model health maintenance organization” has the meaning stated in § 19–713.6 of the Health – General Article.
    (d)    “Health maintenance organization” has the meaning stated in § 19–701(g) of the Health – General Article.
    (e)    (1)    “Institutional facility” means a facility other than a nursing home whose primary purpose is to provide a physical environment for patients to obtain inpatient or emergency care.
        (2)    “Institutional facility” does not include an urgent care facility that is not part of a facility.
    (f)    “Prescriber–pharmacist agreement” means an agreement between an authorized prescriber and a licensed pharmacist that is disease–state specific and specifies the protocols that may be used.
    (g)    “Protocol” means a course of treatment predetermined by the authorized prescriber and licensed pharmacist according to generally accepted medical practice for the proper completion of a particular therapeutic or diagnostic intervention.
    (h)    “Therapy management contract” means a voluntary, written arrangement that is:
        (1)    Disease–state specific;
        (2)    Signed by:
            (i)    One licensed pharmacist and the licensed pharmacist’s designated alternate licensed pharmacists;
            (ii)    One authorized prescriber and alternate designated authorized prescribers involved directly in patient care; and
            (iii)    One patient receiving care from an authorized prescriber and a licensed pharmacist pursuant to a prescriber–pharmacist agreement and protocol under this subtitle; and
        (3)    Related to treatment using drug therapy, laboratory tests, or medical devices, under defined conditions or limitations for the purpose of improving patient outcomes.